Index -
P/E -
EPS (ttm) -0.34
Insider Own 13.37%
Shs Outstand 96.27M
Perf Week 4.04%
Market Cap 5.65B
Forward P/E 22.09
EPS next Y 2.66
Insider Trans -0.03%
Shs Float 83.40M
Perf Month 18.65%
Income 17.60M
PEG -
EPS next Q 0.47
Inst Own 78.23%
Short Float 4.96%
Perf Quarter 42.49%
Sales 2.71B
P/S 2.09
EPS this Y 26.79%
Inst Trans 1.82%
Short Ratio 4.29
Perf Half Y 26.12%
Book/sh 6.95
P/B 8.45
EPS next Y 33.52%
ROA 0.20%
Short Interest 4.14M
Perf Year 91.27%
Cash/sh 11.78
P/C 4.98
EPS next 5Y 29.38%
ROE 2.83%
52W Range 26.62 - 60.35
Perf YTD 36.02%
Dividend Est. 1.70 (2.89%)
P/FCF 91.41
EPS past 5Y -
ROI 0.91%
52W High -2.71%
Beta 1.52
Dividend TTM 1.75 (2.98%)
Quick Ratio -
Sales past 5Y 29.25%
Gross Margin 96.45%
52W Low 120.59%
ATR (14) 1.70
Dividend Ex-Date Aug 16, 2024
Current Ratio -
EPS Y/Y TTM -80.99%
Oper. Margin -0.76%
RSI (14) 76.56
Volatility 2.81% 2.78%
Employees 1850
Debt/Eq 1.72
Sales Y/Y TTM 21.75%
Profit Margin 0.65%
Recom 2.07
Target Price 51.29
Option/Short Yes / Yes
LT Debt/Eq 1.72
EPS Q/Q -1327.15%
Payout -
Rel Volume 1.81
Prev Close 59.33
Sales Surprise -0.53%
EPS Surprise 14.92%
Sales Q/Q 23.04%
Earnings Aug 06 BMO
Avg Volume 963.78K
Price 58.72
SMA20 12.82%
SMA50 19.44%
SMA200 33.14%
Trades
Volume 1,745,374
Change -1.03%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-12-24 Initiated
Wells Fargo
Overweight
$60
May-10-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$43 → $52
Jan-04-24 Initiated
TD Cowen
Market Perform
$38
Dec-06-23 Resumed
BMO Capital Markets
Market Perform
$36
Nov-30-23 Resumed
Goldman
Buy
$43
May-19-23 Initiated
Citigroup
Buy
$32
Jan-24-23 Downgrade
JP Morgan
Overweight → Neutral
$35 → $34
Oct-19-22 Initiated
Credit Suisse
Neutral
$27.50
Oct-17-22 Initiated
Jefferies
Hold
$30
Oct-14-22 Downgrade
Exane BNP Paribas
Outperform → Neutral
$32
Jun-08-22 Initiated
JMP Securities
Mkt Perform
Show Previous Ratings
Sep-16-24 09:05PM
Sep-11-24 07:55AM
Sep-06-24 03:08PM
Sep-03-24 04:20PM
04:05PM
05:46AM
Loading…
Aug-23-24 05:46AM
Aug-22-24 09:00AM
Aug-15-24 01:00AM
Aug-06-24 03:39PM
(The Wall Street Journal)
08:00AM
Jul-18-24 12:06AM
Jul-16-24 04:49AM
Jul-10-24 08:00AM
Jul-04-24 12:00PM
Jun-28-24 08:00AM
07:55AM
Loading…
07:55AM
Jun-17-24 09:30AM
Jun-08-24 05:30PM
May-29-24 08:00AM
May-22-24 08:07AM
May-08-24 12:54PM
09:25AM
08:00AM
May-02-24 01:00PM
May-01-24 10:01AM
Apr-24-24 12:10PM
Apr-17-24 09:00AM
Apr-15-24 09:02AM
(The Wall Street Journal)
Apr-04-24 08:00AM
Apr-03-24 08:00AM
01:13AM
Loading…
Mar-29-24 01:13AM
Mar-24-24 11:00AM
Mar-07-24 10:05AM
(The Wall Street Journal)
Mar-04-24 09:40AM
Mar-01-24 11:36PM
Feb-29-24 05:25PM
09:19AM
Feb-28-24 09:10PM
Feb-27-24 08:50AM
Feb-26-24 09:11AM
06:25AM
Feb-21-24 09:06AM
Feb-20-24 01:46PM
Feb-19-24 01:16PM
Feb-14-24 08:00AM
Feb-13-24 09:25AM
08:00AM
Feb-06-24 10:00AM
Feb-05-24 10:27AM
Jan-24-24 06:32PM
Jan-23-24 04:58PM
08:47AM
08:00AM
Jan-18-24 05:46PM
Jan-16-24 03:48PM
(The Wall Street Journal)
09:00AM
Jan-11-24 08:00AM
Jan-10-24 08:00AM
Dec-27-23 07:47AM
Dec-18-23 01:24PM
Dec-15-23 07:55AM
Dec-01-23 06:06AM
Nov-21-23 08:00AM
Nov-07-23 03:20PM
(The Wall Street Journal)
08:00AM
05:30AM
(The Wall Street Journal)
Nov-06-23 08:33AM
Nov-02-23 07:00AM
Oct-11-23 08:00AM
Oct-02-23 08:00AM
Sep-25-23 01:33PM
Sep-20-23 12:13AM
Sep-19-23 09:00AM
Sep-13-23 08:30AM
Sep-05-23 12:31PM
08:00AM
Aug-28-23 12:00PM
Aug-12-23 08:04AM
Aug-09-23 08:40AM
Aug-08-23 08:00AM
Jul-31-23 01:39PM
(The Wall Street Journal)
Jul-27-23 04:05PM
Jul-19-23 11:31AM
Jul-11-23 08:30AM
Jul-10-23 07:00AM
Jun-09-23 08:18AM
Jun-05-23 08:30AM
May-18-23 07:12AM
May-17-23 04:31PM
(The Wall Street Journal)
May-15-23 03:54PM
(The Wall Street Journal)
06:30AM
06:30AM
May-03-23 09:00AM
May-02-23 04:30PM
Apr-20-23 08:30AM
Apr-04-23 12:00PM
Mar-31-23 06:30AM
(The Wall Street Journal)
Feb-16-23 06:31AM
Feb-15-23 08:00AM
Jan-18-23 08:30AM
TPG, Inc. operates as a global, diversified alternative asset management firm. It invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions. The firm aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment strategy and performance of its portfolio. The company was founded by Jim Coulter and David Bonderman in 1992 and is headquartered in Fort Worth, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MESSEMER DEBORAH M. Director Jul 17 '24 Sale 46.55 4,089 190,332 17,536 Jul 17 05:37 PM MESSEMER DEBORAH M. Director Feb 28 '24 Sale 43.97 6,390 280,980 18,033 Mar 01 05:14 PM Vazquez-Ubarri Anilu Chief Operating Officer Feb 27 '24 Option Exercise 0.00 101,937 0 435,648 Feb 29 07:23 PM Vazquez-Ubarri Anilu Chief Operating Officer Feb 29 '24 Sale 41.64 101,937 4,244,657 333,711 Feb 29 07:23 PM WINKELRIED JON Chief Executive Officer Feb 27 '24 Option Exercise 0.00 1,000,000 0 4,326,460 Feb 29 07:01 PM WINKELRIED JON Chief Executive Officer Feb 29 '24 Sale 41.64 1,000,000 41,640,000 3,326,460 Feb 29 07:01 PM WINKELRIED JON Chief Executive Officer Feb 29 '24 Sale 41.64 50,848 2,117,311 0 Feb 29 07:01 PM Weingart Jack Chief Financial Officer Feb 27 '24 Option Exercise 0.00 308,468 0 1,084,450 Feb 29 06:57 PM Weingart Jack Chief Financial Officer Feb 29 '24 Sale 41.64 308,468 12,844,608 775,982 Feb 29 06:57 PM Trujillo David Director Feb 27 '24 Option Exercise 0.00 397,510 0 580,029 Feb 29 06:45 PM Trujillo David Director Feb 29 '24 Sale 41.64 397,510 16,552,316 182,519 Feb 29 06:45 PM Sisitsky Todd Benjamin President Feb 27 '24 Option Exercise 0.00 660,151 0 1,172,917 Feb 29 06:43 PM Sisitsky Todd Benjamin President Feb 29 '24 Sale 41.64 660,151 27,488,688 512,766 Feb 29 06:43 PM Sisitsky Todd Benjamin President Feb 29 '24 Sale 41.64 52,807 2,198,883 396,982 Feb 29 06:43 PM Sarvananthan Ganendran Director Feb 27 '24 Option Exercise 0.00 162,707 0 215,093 Feb 29 06:41 PM Sarvananthan Ganendran Director Feb 29 '24 Sale 41.64 172,705 7,191,436 42,388 Feb 29 06:41 PM Rhodes Jeffrey K. Director Feb 27 '24 Option Exercise 0.00 408,675 0 585,167 Feb 29 06:38 PM Rhodes Jeffrey K. Director Feb 29 '24 Sale 41.64 408,675 17,017,227 176,492 Feb 29 06:38 PM Raj Nehal Director Feb 27 '24 Option Exercise 0.00 250,858 0 800,570 Feb 29 06:36 PM Raj Nehal Director Feb 29 '24 Sale 41.64 250,858 10,445,727 549,712 Feb 29 06:36 PM Harris Joann Chief Compliance Officer Feb 27 '24 Option Exercise 0.00 23,745 0 23,745 Feb 29 06:33 PM Harris Joann Chief Compliance Officer Feb 29 '24 Sale 41.64 23,745 988,742 0 Feb 29 06:33 PM Harris Joann Chief Compliance Officer Feb 29 '24 Sale 41.64 1,739 72,412 22,860 Feb 29 06:33 PM Davis Kelvin L. Director Feb 27 '24 Option Exercise 0.00 822,017 0 1,666,601 Feb 29 06:29 PM Davis Kelvin L. Director Feb 29 '24 Sale 41.64 822,017 34,228,788 844,584 Feb 29 06:29 PM Davidson Martin Chief Accounting Officer Feb 27 '24 Option Exercise 0.00 39,317 0 70,308 Feb 29 06:26 PM Davidson Martin Chief Accounting Officer Feb 29 '24 Sale 41.64 39,317 1,637,160 30,991 Feb 29 06:26 PM COULTER JAMES G Executive Chairman Feb 27 '24 Option Exercise 0.00 1,250,000 0 1,266,949 Feb 29 06:24 PM COULTER JAMES G Executive Chairman Feb 29 '24 Sale 41.64 1,334,746 55,578,823 0 Feb 29 06:24 PM COULTER JAMES G Executive Chairman Feb 29 '24 Sale 41.64 16,949 705,756 386,936 Feb 29 06:24 PM COSLET JONATHAN J Director Feb 27 '24 Option Exercise 0.00 1,000,000 0 1,000,000 Feb 29 06:22 PM COSLET JONATHAN J Director Feb 29 '24 Sale 41.64 1,000,000 41,640,000 0 Feb 29 06:22 PM Chorengel Maya Director Feb 27 '24 Option Exercise 0.00 69,298 0 131,919 Feb 29 06:20 PM Chorengel Maya Director Feb 29 '24 Sale 41.64 74,773 3,113,548 57,146 Feb 29 06:20 PM BONDERMAN DAVID Director Feb 27 '24 Option Exercise 0.00 1,500,000 0 1,516,949 Feb 29 06:18 PM BONDERMAN DAVID Director Feb 29 '24 Sale 41.64 1,584,746 65,988,823 0 Feb 29 06:18 PM BONDERMAN DAVID Director Feb 29 '24 Sale 41.64 16,949 705,756 37,967 Feb 29 06:18 PM Berenson Bradford General Counsel Feb 27 '24 Option Exercise 0.00 90,895 0 287,147 Feb 29 06:15 PM Berenson Bradford General Counsel Feb 29 '24 Sale 41.64 90,895 3,784,868 196,252 Feb 29 06:15 PM
Index RUT
P/E -
EPS (ttm) -1.61
Insider Own 34.69%
Shs Outstand 167.13M
Perf Week -5.41%
Market Cap 585.51M
Forward P/E -
EPS next Y -1.49
Insider Trans 2.39%
Shs Float 136.57M
Perf Month 2.19%
Income -278.45M
PEG -
EPS next Q -0.33
Inst Own 66.87%
Short Float 28.51%
Perf Quarter 9.80%
Sales 0.09M
P/S 6505.64
EPS this Y 32.39%
Inst Trans 4.06%
Short Ratio 15.85
Perf Half Y -36.07%
Book/sh 2.46
P/B 1.14
EPS next Y -5.29%
ROA -39.28%
Short Interest 38.94M
Perf Year -25.73%
Cash/sh 2.13
P/C 1.32
EPS next 5Y 1.00%
ROE -48.94%
52W Range 2.01 - 5.78
Perf YTD -12.77%
Dividend Est. -
P/FCF -
EPS past 5Y 22.18%
ROI -46.25%
52W High -51.52%
Beta 0.83
Dividend TTM -
Quick Ratio 12.25
Sales past 5Y -27.79%
Gross Margin -16467.44%
52W Low 39.30%
ATR (14) 0.23
Dividend Ex-Date -
Current Ratio 12.25
EPS Y/Y TTM 34.36%
Oper. Margin -314866.28%
RSI (14) 53.03
Volatility 8.09% 8.38%
Employees 233
Debt/Eq 0.18
Sales Y/Y TTM -24.70%
Profit Margin -323780.23%
Recom 1.61
Target Price 9.34
Option/Short Yes / Yes
LT Debt/Eq 0.17
EPS Q/Q 34.27%
Payout -
Rel Volume 2.05
Prev Close 2.91
Sales Surprise -99.92%
EPS Surprise 0.00%
Sales Q/Q -100.00%
Earnings Aug 07 AMC
Avg Volume 2.46M
Price 2.80
SMA20 4.05%
SMA50 3.09%
SMA200 -13.10%
Trades
Volume 5,038,024
Change -3.78%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-24 Resumed
Oppenheimer
Outperform
$13 → $11
May-31-24 Initiated
Piper Sandler
Overweight
$11
Jan-05-24 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Jan-05-24 Downgrade
Guggenheim
Buy → Neutral
Dec-08-23 Initiated
Citigroup
Buy
$7
Dec-08-23 Initiated
Citigroup
Buy
Jun-26-23 Resumed
Oppenheimer
Outperform
$28
Mar-21-23 Initiated
Bernstein
Mkt Perform
$6
Jan-24-23 Upgrade
JP Morgan
Neutral → Overweight
$20 → $11
Jan-06-23 Upgrade
Robert W. Baird
Neutral → Outperform
$12
Dec-12-22 Downgrade
BofA Securities
Buy → Underperform
$24 → $9
Aug-10-22 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-15-22 Upgrade
Goldman
Neutral → Buy
$9 → $32
Jun-03-22 Initiated
Robert W. Baird
Neutral
$11
Feb-28-22 Reiterated
B. Riley Securities
Buy
$30 → $21
Oct-20-21 Initiated
Cowen
Outperform
Oct-08-21 Downgrade
Stifel
Buy → Hold
$44 → $18
Oct-08-21 Downgrade
Goldman
Buy → Neutral
$71 → $20
Sep-23-21 Upgrade
Raymond James
Mkt Perform → Outperform
Jun-21-21 Resumed
Jefferies
Buy
$53
Show Previous Ratings
Sep-14-24 05:39PM
Sep-06-24 11:31AM
Aug-08-24 09:50AM
08:30AM
06:00AM
04:10PM
Loading…
Aug-07-24 04:10PM
(Associated Press Finance)
04:02PM
Jul-31-24 08:30AM
Jul-01-24 08:30AM
Jun-27-24 10:13AM
Jun-26-24 04:36PM
Jun-20-24 08:30AM
Jun-12-24 11:30AM
May-29-24 08:55AM
May-28-24 04:05PM
08:30AM
Loading…
May-23-24 08:30AM
May-21-24 01:56PM
Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More
(Insider Monkey)
08:16AM
May-16-24 08:13AM
May-14-24 12:56PM
09:14AM
08:21AM
03:06AM
May-13-24 08:55PM
05:36PM
05:10PM
04:47PM
04:17PM
(Associated Press Finance)
04:14PM
04:01PM
08:30AM
Loading…
May-06-24 08:30AM
Apr-26-24 10:32AM
08:30AM
Apr-24-24 10:01AM
Apr-11-24 02:45PM
Apr-09-24 08:30AM
Apr-08-24 08:46AM
Mar-16-24 04:35PM
Mar-15-24 09:32AM
07:04AM
(Thomson Reuters StreetEvents)
Mar-14-24 08:55PM
05:34PM
05:15PM
04:15PM
(Associated Press Finance)
04:05PM
Mar-13-24 12:15PM
Mar-12-24 08:50AM
08:30AM
Mar-05-24 09:55AM
08:30AM
Feb-28-24 08:30AM
Feb-16-24 08:30AM
Jan-16-24 04:05PM
Jan-12-24 08:34AM
Jan-05-24 12:52PM
08:25AM
08:13AM
Jan-04-24 04:15PM
04:05PM
11:05AM
Jan-03-24 04:05PM
Dec-09-23 12:00PM
Dec-01-23 08:30AM
Nov-24-23 06:40AM
Nov-10-23 12:00PM
Nov-03-23 12:15PM
12:00PM
12:00PM
10:15AM
Nov-02-23 07:33PM
04:12PM
(Associated Press Finance)
04:02PM
09:00AM
Oct-30-23 08:30AM
Oct-26-23 08:30AM
Oct-16-23 09:26AM
08:30AM
Sep-27-23 09:09AM
Sep-25-23 08:45AM
Sep-05-23 08:30AM
Aug-29-23 07:30AM
Aug-23-23 12:26PM
Aug-17-23 08:44AM
Aug-14-23 08:30AM
Aug-03-23 11:20AM
Aug-02-23 05:25PM
04:13PM
04:02PM
10:41AM
Jul-26-23 08:30AM
Jun-15-23 09:30AM
Jun-14-23 08:00AM
Jun-09-23 06:25PM
08:02AM
Jun-03-23 09:00AM
Jun-02-23 11:31AM
May-31-23 12:02PM
10:46AM
May-29-23 07:48AM
May-26-23 10:51AM
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Douglas Earl Martin Officer Aug 21 '24 Proposed Sale 2.79 28,310 78,844 Aug 21 04:18 PM MESSEMER DEBORAH M. Director Jun 18 '24 Sale 2.28 18,641 42,488 166,765 Jun 20 04:31 PM Humer Franz B Director May 30 '24 Sale 2.34 11,200 26,181 255,253 Jun 03 04:09 PM Belldegrun Arie Director May 16 '24 Buy 2.90 1,724,137 4,999,997 1,724,137 May 20 09:33 PM Parker Geoffrey M. CHIEF FINANCIAL OFFICER Jan 30 '24 Buy 3.60 190 683 819,590 Mar 06 09:52 PM MESSEMER DEBORAH M. Director Dec 18 '23 Sale 2.70 18,640 50,317 62,456 Dec 20 04:26 PM
Index NDX, S&P 500
P/E 18.59
EPS (ttm) 4.13
Insider Own 0.40%
Shs Outstand 1.07B
Perf Week 9.50%
Market Cap 78.47B
Forward P/E 15.93
EPS next Y 4.82
Insider Trans -0.11%
Shs Float 1.02B
Perf Month 7.42%
Income 4.44B
PEG 0.96
EPS next Q 1.06
Inst Own 71.45%
Short Float 2.23%
Perf Quarter 26.65%
Sales 31.04B
P/S 2.53
EPS this Y -13.30%
Inst Trans 1.53%
Short Ratio 1.85
Perf Half Y 16.06%
Book/sh 19.98
P/B 3.84
EPS next Y 8.97%
ROA 5.60%
Short Interest 22.68M
Perf Year 26.13%
Cash/sh 13.32
P/C 5.76
EPS next 5Y 19.45%
ROE 22.03%
52W Range 50.25 - 78.25
Perf YTD 25.00%
Dividend Est. -
P/FCF 11.71
EPS past 5Y 17.54%
ROI 14.32%
52W High -1.90%
Beta 1.44
Dividend TTM -
Quick Ratio 1.24
Sales past 5Y 14.06%
Gross Margin 39.61%
52W Low 52.76%
ATR (14) 2.16
Dividend Ex-Date -
Current Ratio 1.24
EPS Y/Y TTM 15.58%
Oper. Margin 17.58%
RSI (14) 70.04
Volatility 2.81% 2.80%
Employees 27200
Debt/Eq 0.63
Sales Y/Y TTM 10.24%
Profit Margin 14.30%
Recom 2.14
Target Price 80.35
Option/Short Yes / Yes
LT Debt/Eq 0.50
EPS Q/Q 16.64%
Payout 0.00%
Rel Volume 2.23
Prev Close 77.57
Sales Surprise 0.79%
EPS Surprise 20.34%
Sales Q/Q 8.40%
Earnings Jul 30 BMO
Avg Volume 12.24M
Price 76.76
SMA20 7.36%
SMA50 15.55%
SMA200 21.43%
Trades
Volume 27,251,620
Change -1.04%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-09-24 Upgrade
Daiwa Securities
Neutral → Outperform
$68 → $72
Jul-31-24 Upgrade
Bernstein
Mkt Perform → Outperform
$71 → $78
Jul-31-24 Upgrade
Argus
Hold → Buy
Jul-18-24 Downgrade
William Blair
Outperform → Mkt Perform
Jul-02-24 Upgrade
Susquehanna
Neutral → Positive
$71
Jun-24-24 Resumed
Goldman
Neutral
$69
May-31-24 Initiated
New Street
Buy
$80
May-30-24 Upgrade
Mizuho
Neutral → Buy
$68 → $90
Apr-29-24 Reiterated
Monness Crespi & Hardt
Buy
$80 → $88
Feb-13-24 Downgrade
Daiwa Securities
Outperform → Neutral
$64 → $62
Feb-09-24 Downgrade
DZ Bank
Buy → Hold
$60
Feb-09-24 Downgrade
Argus
Buy → Hold
Feb-08-24 Reiterated
Monness Crespi & Hardt
Buy
$95 → $80
Jan-29-24 Reiterated
Monness Crespi & Hardt
Buy
$100 → $95
Jan-16-24 Downgrade
Mizuho
Buy → Neutral
$72 → $65
Jan-09-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$118 → $66
Jan-05-24 Downgrade
BTIG Research
Buy → Neutral
Jan-04-24 Downgrade
Oppenheimer
Outperform → Perform
Dec-06-23 Downgrade
BofA Securities
Buy → Neutral
$77 → $66
Dec-05-23 Resumed
BMO Capital Markets
Market Perform
$65
Show Previous Ratings
Today 01:47PM
09:37AM
Sep-19-24 10:37AM
(Yahoo Finance Video) +6.09%
08:20AM
Sep-18-24 05:45PM
01:55PM
Loading…
01:55PM
12:24PM
(Investor's Business Daily)
07:58AM
Sep-17-24 05:15AM
Sep-16-24 08:52AM
06:11AM
Sep-15-24 10:55AM
Sep-14-24 04:30PM
02:55PM
05:45AM
12:55PM
Loading…
Sep-13-24 12:55PM
06:50AM
Sep-12-24 06:16PM
05:45PM
09:40AM
06:19AM
05:36AM
Sep-11-24 09:37PM
09:08PM
05:43PM
12:35PM
10:00AM
Sep-10-24 12:00PM
09:00AM
05:11AM
05:59PM
Loading…
Sep-09-24 05:59PM
12:18PM
08:00AM
07:00AM
Sep-07-24 03:06PM
06:18AM
05:40AM
Sep-06-24 04:00PM
07:35AM
05:55AM
05:45AM
Sep-05-24 08:05AM
08:00AM
(Investor's Business Daily)
08:00AM
07:21AM
04:06AM
Sep-04-24 05:18AM
04:00AM
Aug-31-24 12:17PM
Aug-30-24 09:00AM
05:45AM
Aug-29-24 04:14PM
02:07PM
11:31AM
10:00AM
07:00AM
Aug-27-24 03:21PM
04:04AM
02:53AM
Aug-26-24 08:42PM
03:56PM
02:40PM
10:00AM
Aug-25-24 02:16AM
Aug-23-24 03:45PM
Aug-22-24 03:39PM
09:00AM
Aug-21-24 08:31PM
Aug-20-24 05:25PM
01:30PM
10:03AM
07:03AM
07:00AM
Aug-19-24 09:00AM
Aug-18-24 06:14PM
08:30AM
Aug-17-24 08:00AM
(The Wall Street Journal)
06:50AM
Aug-16-24 10:34AM
Aug-15-24 05:23PM
(Investor's Business Daily)
02:02PM
Aug-14-24 10:28AM
Aug-11-24 08:31AM
03:00AM
Aug-09-24 01:51PM
10:33AM
09:53AM
05:00AM
Aug-08-24 07:39AM
04:40AM
Aug-06-24 12:35PM
09:00AM
09:00AM
Aug-05-24 09:40AM
07:52AM
05:35AM
05:13AM
Aug-04-24 12:25PM
03:15AM
Aug-03-24 06:25AM
PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Keller Frank EVP, GM, Lg Ent & Mer Plat. Sep 01 '24 Option Exercise 0.00 3,296 0 28,386 Sep 03 07:34 PM Keller Frank EVP, GM, Lg Ent & Mer Plat. Jun 01 '24 Option Exercise 0.00 3,296 0 26,726 Jun 03 09:01 PM MESSEMER DEBORAH M. Director May 24 '24 Sale 61.65 4,422 272,616 13,976 May 24 05:09 PM Keller Frank SVP, GM, Lg Ent & Mer Plat. Mar 01 '24 Sale 60.64 7,686 466,077 23,430 Mar 04 06:26 PM Karczmer Aaron EVP, Chief Enterprise Services Mar 01 '24 Option Exercise 0.00 24,617 0 155,909 Mar 04 06:19 PM Keller Frank SVP, GM, Lg Ent & Mer Plat. Mar 01 '24 Option Exercise 0.00 12,010 0 35,440 Mar 04 06:15 PM Alford Peggy EVP, Global Sales Dec 01 '23 Option Exercise 0.00 3,069 0 43,670 Dec 04 08:00 PM Auerbach Jonathan Chief Strat., Gr & Data Ofr Dec 01 '23 Option Exercise 0.00 3,069 0 82,120 Dec 04 07:59 PM Karczmer Aaron EVP, Chief Enterprise Services Dec 01 '23 Option Exercise 0.00 3,069 0 125,929 Dec 04 07:59 PM Alford Peggy EVP, Global Sales Nov 27 '23 Sale 56.76 15,000 851,428 40,601 Nov 28 05:45 PM Auerbach Jonathan Chief Strat., Gr & Data Ofr Nov 21 '23 Sale 55.58 64,957 3,610,373 79,051 Nov 22 05:45 PM Scheibe Gabrielle Acting CFO & SVP, IR & Treas. Oct 15 '23 Option Exercise 0.00 4,607 0 34,826 Oct 17 08:18 PM Kim John C. EVP, Chief Product Officer Oct 15 '23 Option Exercise 0.00 22,114 0 22,715 Oct 17 08:14 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite